Peginterferon alfa-2b (SCH 054031)

BIOLOGICAL2 trials

Sponsors

Merck Sharp & Dohme LLC, Schering-Plough

Conditions

HIV InfectionsHepacivirusHepatitis C, Chronic

Phase 4

Efficacy and Safety of PegIntron Plus Ribavirin for Treatment of Chronic Hepatitis C in HIV-Infected Subjects (Study P04469)(TERMINATED)

TerminatedNCT00687544

Merck Sharp & Dohme LLCHepacivirus, Hepatitis C, Chronic, HIV Infections

Start: 2005-12-31End: 2008-09-30Updated: 2017-04-06

PEG-IFN Alfa-2b Plus Ribavirin for Treatment of Mexican naïve Patients With Chronic Hepatitis C Infected With Genotype 1 (Study P04511)(COMPLETED)

CompletedNCT00724620

Schering-PloughHepatitis C, Chronic

Start: 2005-06-30End: 2008-02-29Updated: 2008-07-29